Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections.

Diabetic foot infections, a frequent and serious cause of morbidity in patients with diabetes mellitus, are caused by anaerobic and aerobic bacteria. Given the fact that seriously impaired host defense factors are almost always present in these patients, bactericidal agents with a broad spectrum of antimicrobial activity are required for their treatment. Seventy-four patients with diabetic foot infections were treated with parenteral sulbactam-ampicillin (1.5 g, q.i.d.). All patients were followed-up prospectively in order to determine the efficacy and safety of sulbactam-ampicillin. The mean duration (+/- SD) of treatment in patients with osteomyelitis (n = 49) and soft tissue infections (n = 25) was 41 +/- 5 and 14 +/- 3 days, respectively. Infected limbs were amputated at various levels in 14 patients (19%). Clinical cure rates were 86% and 100% in patients with osteomyelitis and with soft tissue infection, respectively. The most frequent side effect was diarrhea and observed in 10 patients (14%). The results of the present study indicate that sulbactam-ampicillin is safe and effective in the treatment of diabetic foot infections.

Does gonadotropin-releasing hormone administration affect serum growth hormone levels in poorly controlled insulin-dependent and non-insulin-dependent diabetes mellitus?

Exaggerated growth hormone (GH) responses to various provocative stimuli have been reported previously in insulin-dependent diabetes mellitus (IDDM). Little is known about GH response to synthetic gonadotropin-releasing hormone (GnRH) in diabetes. It has been reported to be exaggerated in active acromegaly. We investigated GH, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels after GnRH administration in seven IDDM and eight non-insulin-dependent diabetic (NIDDM) patients. They were poorly controlled from a metabolic point of view. Ten healthy subjects served as the control group. FSH and LH levels increased significantly after GnRH in all groups. In contrast, GnRH did not elicit significant GH increments above baseline levels in any group. Moreover, mean areas under the GH curves were comparable among the three groups. These results suggest that poorly controlled IDDM and NIDDM does not lead to inappropriate GH responses to GnRH.

An unusual scintigraphic pattern of benign thyroid nodules. The "fish eye" sign.

The authors describe three cases of an unusual scintigraphic pattern of benign thyroid nodule with ultrasonographic appearance. A nodule of normal, increased and decreased Tc-99m pertechnetate concentration surrounded by a rim of cold area was noticed in three patients in whom fine-needle aspiration biopsies revealed benign follicular cells.

Impaired lung epithelial permeability in diabetics detected by technetium-99m-DTPA aerosol scintigraphy.

UNLABELLED: The clearance of inhaled 99mTc-diethyl triaminepentaacetic acid (DTPA) aerosol from the lungs is used as an index of lung epithelial permeability. We investigated the involvement of the lung in diabetic patients using 99mTc-DTPA aerosol scintigraphy. METHODS: A total of 33 diabetic patients were studied. Thirteen had complications such as retinopathy and/or nephropathy (Group A) and 20 were without complications (Group B). As a control group, 20 healthy nonsmokers were studied. Dynamic scintigrams (2 min/frame, up to 30 min) were obtained following inhalation of 99mTc-DTPA through a radioaerosol delivery system. Time-activity curves were obtained and half-time (T1/2) of DTPA was measured from the curves. RESULTS: The mean T1/2 values (min +/- s.d.) were calculated to be 133.05 +/- 46.97, 93.67 +/- 21.23, 91.97 +/- 18.21 (Group A, Group B and controls, respectively). The mean T1/2 of Group A was significantly longer than controls (p < 0.005) and than that of Group B (p < 0.005) indicating decreased epithelial permeability. No such statistical difference was detected between Group B and controls (p > 0.05). CONCLUSION: The lung is a target organ in diabetes and lung involvement is closely related to other vascular complications. The presence of lung involvement can be readily detected by 99mTc-DTPA aerosol scintigraphy.

The effect of radioactive iodine treatment on thyroid C cells.

To determine the effect of radioiodine treatment on thyroid C cells, calcitonin (CT) levels were measured by RIA before and after intravenous calcium stimulation (2 mg/kg body-weight elemental calcium) in 22 women treated with 131I for hyperthyroidism. The results were compared with sex, age and weight-matched normal controls. There was a slight but statistically significant decrease in basal CT levels of the patients compared to the control group (mean +/- SE; 0.009 +/- 0.001 vs 0.011 +/- 0.001 pmol/l, P less than 0.05). The mean stimulated CT level of the patient group was significantly lower than that of the controls (0.010 +/- 0.001 vs. 0.018 +/- 0.003 pmol/l, P less than 0.001). The absence or presence of 131I-induced hypothyroidism at the time of the study did not influence basal or stimulated CT levels. Basal and stimulated CT levels were significantly lower in the patients with Graves' disease than in the patients with toxic nodular goitre. We conclude that 131I used to correct hyperthyroidism may cause marked CT deficiency.

Failure of cyproheptadine to affect calcium homoeostasis and PTH levels in primary hyperparathyroidism.

In this study we evaluated the influence of cyproheptadine treatment on serum PTH values, as well as serum Ca, Mg and P levels in patients with primary hyperparathyroidism. For this purpose, cyproheptadine was given in a dose of 4 mg orally every 4 hours during 10 consecutive days to six patients with primary hyperparathyroidism. Control fasting blood samples for PTH, Ca, Mg and P were obtained every other day for a week. Afterwards cyproheptadine treatment was applied as mentioned above. Then blood samples were taken on the 4th, 6th, and 10th day of treatment to determine serum PTH, Ca, Mg and P. Before treatment the mean PTH (+/- SE) values were 22.95 +/- 1.4 mlU/ml and during cyproheptadine treatment were 23.06 +/- 0.9, 22.95 +/- 0.8, 22.32 +/- 0.8 mlU/ml, respectively. There were no significant changes in serum PTH levels before and during treatment (P greater than 0.05). Also serum Ca, Mg and P levels remained unchanged. Our data suggest that cyproheptadine treatment does not affect calcium homoeostasis and serum PTH levels in primary hyperparathyroidism.

Non-invasive assessment of left ventricular function in diabetics without clinical heart disease.

Left ventrical performance was assessed by systolic and diastolic time intervals measured echocardiographically in 24 diabetic patients without clinical heart disease and in 18 healthy subjects. It was found that diabetics had longer PEP, higher PEP/LVET ratio and longer IVRT (p less than 0.01). The possible pathogenetic explanations of these abnormalities are discussed and it is concluded that the measurement of time intervals is a useful method for detecting this myocardial dysfunction on the preclinical stage.